ArticleThe CRISPR journal2023

Pan-Coronavirus CRISPR-CasRx Effector System Significantly Reduces Viable Titer in HCoV-OC43, HCoV-229E, and SARS-CoV-2.

Cathryn M Mayes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.